IPO Profile: Intersect ENT Inc

Kleiner Perkins, Norwest and other investors put more than $84 milllion into the company, developing treatments for the ear, nose and throat

ByLarry Oberfeld

1 August 2014•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.